Damofecia Tablet (Finasteride)

Adult dose

Typically, 1 mg of finasteride is administered orally once daily, with or without meals. Generally, treatment effects can be seen after 3 months of continuous use, and it is recommended to continue for maintaining therapeutic effects. The treatment duration and efficacy should be continuously evaluated. If discontinued, therapeutic effects will diminish within 12 months.

This medication should not be used by children or women. In particular, pregnant women or women who may become pregnant should not handle broken pieces of this medication, as its ingredients may be absorbed through the skin and could harm a male fetus. Depression or mood changes may occur during the use of this medication, so if such symptoms develop, medical consultation is necessary immediately. This medication should not be given to pregnant women, patients with allergies to this drug, and patients with specific genetic lactose intolerance. Patients who are currently taking other 5-alpha reductase inhibitors should not take this drug concurrently. Patients with poor liver function or issues with fat metabolism should be cautious when using this medication. This medication may cause sexual dysfunction issues such as decreased libido, erectile dysfunction, and ejaculatory disorders, and if these symptoms occur, the drug should be discontinued and medical advice should be sought. In most cases, symptoms will resolve after discontinuing the drug. The drug may rarely cause side effects such as breast tenderness or enlargement, allergic reactions, muscle pain, and psychiatric symptoms. If there are changes such as lumps, pain, or discharge in the breast during use, medical consultation should be sought immediately. This medication is known to have no significant interactions with other drugs, but it is advisable to consult healthcare professionals when using it alongside other medications. Animal studies during pregnancy have reported genital abnormalities in male fetuses, so pregnant women should take care to avoid exposure to this drug. This medication is not administered to women, and its safety in breastfeeding mothers has not been established. No special dosage adjustments are necessary for elderly patients aged 65 years and older, although studies on the drug's efficacy in this population are limited. While taking this medication, PSA levels may decrease in blood tests, so caution is needed in interpreting test results. There are no specific detoxification methods for overdose, and immediate medical attention should be sought in case of serious side effects. Keep this medication out of reach of children and avoid transferring it to other containers. While long-term use has not reported carcinogenicity or severe organ damage, caution is warranted as some animal studies have observed effects on reproductive function.

Serious side effects

Hives, angioedema (swelling of lips, tongue, throat, and face), rash

Mild side effects

Decreased libido, erectile dysfunction, ejaculatory disorders (reduction in semen), breast enlargement, breast tenderness, testicular pain, blood-stained urine, dizziness, headache, palpitations, increased liver enzyme levels, muscle pain, weakness, anxiety

This medication is sensitive to air and moisture and should be stored in a sealed container. It is best to maintain the storage temperature between 15 to 30 degrees Celsius. This helps to preserve the effectiveness of the medication.

Appearance

Brownish-yellow, double-convex, octagonal film-coated tablet

Package unit

30 tablets (10 tablets/PTPX3)